Clinical study to investigate the efficacy and safety of iliac stenting in patients with peripheral arterial disease

Clinical study to investigate the efficacy and safety of iliac stenting in patients with peripheral arterial disease - Clinical study to investigate the efficacy and safety of iliac stenting in patients with peripheral arterial disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016264

Enrollment

100

Registered

2015-01-20

Start date

2015-01-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral arterial disease(PAD), Arteriosclerosis obliterans(ASO)

Interventions

Iliac nitinol stent

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) PAD (Rutherford1-4) due to iliac stenosis or occlusion (2) Insufficiency of conservative treatment (3) The patients obtained informed consent (4) The age over 20 years old

Exclusion criteria

Exclusion criteria: (1) PAD (Rutherford5,6) (2) The patients with bleeding disorder or the difficulty of taking the antiplatelet or anticoagulation therapy (3) eGFR < 30 mL/min/1.73m2, except HD patients (4) severe calcification (5) Nitinol or nickel allergy (6) The patients with the difficulty of 1 year follow up

Design outcomes

Primary

Measure	Time frame
12-month restenosis rate	—

Secondary

Measure	Time frame
procedural success rate, adverse events, Death within 30 days, MALE	—

Countries

Japan

Contacts

Public ContactTakuya Matsumoto

Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan Department of Surgery and Science

takum@surg2.med.kyushu-u.ac.jp(81)92-642-5466

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026